Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Fenamic acid is a chemical compound that serves as the parent structure for a class of non-steroidal anti-inflammatory drugs (NSAIDs) known as fenamates, which include mefenamic acid, flufenamic acid, and tolfenamic acid, among others. Structurally, fenamic acid consists of an anthranilic acid derivative with an additional aromatic ring, which enables its ability to inhibit cyclooxygenase (COX) enzymes, thereby reducing the synthesis of prostaglandins involved in inflammation, pain, and fever. This class of NSAIDs is often used in the treatment of mild to moderate pain, such as dysmenorrhea and musculoskeletal discomfort. Despite their therapeutic efficacy, fenamates can be associated with gastrointestinal side effects and require careful consideration in patients with certain health conditions. Research continues to explore the pharmacokinetics and pharmacodynamics of fenamic acid derivatives to enhance their safety profile and therapeutic applications.
仅用于科研。不用于诊断过程。未经明确授权不得转售。